Skip to Content
Merck
CN
  • [Successful treatment of neuroendocrine ductal carcinoma in situ with loco-regional therapy].

[Successful treatment of neuroendocrine ductal carcinoma in situ with loco-regional therapy].

Gan to kagaku ryoho. Cancer & chemotherapy (2014-01-08)
Kenichi Sakurai, Shigeru Fujisaki, Tetsuyo Maeda, Saki Nagashima, Yukiko Hara, Ryouichi Tomita, Shuhei Suzuki, Tomohiro Hirano, Katsuhisa Enomoto, Sadao Amano
ABSTRACT

Herein, we report the use of microdochectomy for neuroendocrine ductal carcinoma in situ( NE-DCIS). The patient was 44-year-old woman who experienced spontaneous nipple discharge for 5 years. We were unable to detect the origin of the nipple discharge by computed tomography (CT), magnetic resonance imaging (MRI), mammography, ductal endoscopy, or ultrasonography. Subsequently, endoscopy-assisted microdochectomy was performed under local anesthesia. Pathological examination of the resected specimen led to a diagnosis of NE-DCIS positive for estrogen and progesterone receptors and negative for HER2/neu protein expression. The Ki-67 positive cell index was 80%. The surgical margins were negative. After surgery, tamoxifen was administered. One year after the operation, the patient is well and metastases have not been noted. This case suggests that endoscopy-assisted microdochectomy under local anesthesia is useful for evaluating spontaneous nipple discharge.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Tamoxifen, ≥99%